256 words
Bristol Myers Scores Two Phase 3 Wins, But A Key Rival Plummets On One
Allison Gatlin covers biotechnology, pharmaceuticals and medical technology. She also oversees coverage of top-performing companies for Investor's Business Daily's The New America page. Allison has worked for Investor's Business Daily since 2015, initially covering semiconductors, solar, cybersecurity and online travel before…